Largest Clinical Trials companies in Germany by Market Capitalization
Germany
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 28.37 B |
Jan. 14, 2025 | USD 116.36 | -0.45% |
|
Germany |
|
| 2 |
USD 941.58 M |
Jan. 14, 2025 | USD 3.95 | -0.95% |
|
Germany |
|
| 3 |
USD 725.65 M |
Jan. 14, 2025 | USD 5.97 | -4.48% |
|
Germany |
|
| 4 |
USD 137.79 M |
Jan. 14, 2025 | USD 2.34 | NA |
|
Germany |
|
| 5 |
USD 54.94 M |
Jan. 14, 2025 | USD 2.11 | 3.12% |
|
Germany |
|
| 6 |
USD 17.54 M |
Jan. 14, 2025 | USD 1.07 | -4.46% |
|
Germany |
|
| 7 |
USD 11.75 M |
Jan. 14, 2025 | USD 5.29 | 13.28% |
|
Germany |
Frequently Asked Questions
-
Which Clinical Trials company in Germany has the highest Market Capitalization ?
The Clinical Trials company in Germany with the highest Market Capitalization is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 28.37 B.
-
Which Clinical Trials company in Germany has the lowest Market Capitalization ?
The Clinical Trials company in Germany with the lowest Market Capitalization is Mainz Biomed B.V. (NasdaqCM: MYNZ) at USD 11.75 M.
-
What are the top 10 Clinical Trials companies in Germany by Market Capitalization ?
The top 10 Clinical Trials companies in Germany by Market Capitalization are BioNTech SE, CureVac N.V., Immatics N.V., InflaRx N.V., Vivoryon Therapeutics N.V., Affimed N.V. and Mainz Biomed B.V..
-
What are the bottom 10 Clinical Trials companies in Germany by Market Capitalization ?
The bottom 10 Clinical Trials companies in Germany by Market Capitalization are Mainz Biomed B.V., Affimed N.V., Vivoryon Therapeutics N.V., InflaRx N.V., Immatics N.V., CureVac N.V. and BioNTech SE.